About Us

Our Story

FidoCure® is a proprietary canine cancer-care service developed by One Health Company, delivering advanced diagnostics and personalized therapeutics for dogs with cancer. Built on cross-species cancer genomics, FidoCure helps veterinarians make more informed treatment decisions while generating insights that benefit both veterinary and human medicine.

FidoCure® was shaped by two firsthand experiences with cancer. Ben Lewis, a former Olympic team kayaker, had early exposure to clinical innovation through advanced medical care during his athletic career. When his dog was later diagnosed with cancer, he pursued access to genomics-informed treatment rarely available in veterinary medicine. His dog outlived the original prognosis and remained cancer-free.

Christina Lopes’ experience was shaped by caring for her father during his battle with terminal lung cancer. Navigating the complexity of cancer care firsthand reinforced a shared conviction: cancer treatment could be more personalized, data-driven, and effective.

Together, Ben Lewis and Christina Lopes co-founded One Health Company to advance cancer care by bridging veterinary and human medicine. FidoCure® was developed as a clinical service to apply this One Health approach in practice—providing veterinarians with advanced diagnostics and access to personalized cancer therapeutics for canine patients.

Our mission is to eradicate canine cancer, improve the quality of life for canine patients, and give new hope to pet parents.

What We Do

Currently, cancer care for dogs lags behind human cancer care by about 20 years. But, from a biological and molecular standpoint, canine cancer is not so different from human cancer. FidoCure uses genomic testing to deduce what therapies may be most effective to treat your dog’s specific type of cancer. From there, precision medicine can be prescribed by your vet and administered in the comfort of your home.

Our goal is to improve the outcome for canine cancer patients. We are the first and only company to offer the information needed to work with your veterinarian on targeted medicines for dogs with cancer.

Our Team

Our Medical & Veterinary Advisors

We have assembled a board of medical and veterinary advisors including multidisciplinary thinkers in the areas of canine and human oncology. They boldly use all of our resources to positively impact the outcome for dogs with cancer. Our vets have treated thousands of dogs over the past 30 years and work closely with our growing network of forward-thinking veterinarians throughout the US.